Big Pharma Earnings Watch: GlaxoSmithKline
Big Pharma Giants Now Three for Three Besting Forecasts After Hiking Prices… Read More
© 2026 CSRXP- All Rights Reserved
CSRxP Applauds Grassley, Wyden for Moving Ahead on Drug Pricing Package
Looks Forward to Working With Senate Finance Members to Hold Big Pharma… Read More
Big Pharma Earnings Watch: Novartis
Drug Makers’ Shares Hit ‘All-Time High’ Off Of Price-Gouging American… Read More
Big Pharma Earnings Watch: Johnson & Johnson
Drug Maker Bests Q2 Forecasts After Hiking Prices on Dozens of Drugs in 2019… Read More
CSRxP Encourages House E&C Lawmakers to Advance FAIR Drug Pricing Act
Greater List Price Transparency Will Help Hold Big Pharma Accountable… Read More
Big Pharma Watch: Manufacturers Thumb Nose at Drug Price Crisis
Drug Makers Continue Price-Gouging Patients as Americans Demand Accountability… Read More
Second Opinion: Correcting Big Pharma’s Claims On The Rebate Rule
America’s seniors and taxpayers received a huge win today when the… Read More
CSRxP Applauds Administration for Withdrawal of Controversial Rebate Rule
Decision to Sideline Misguided Proposal a Huge Win for America’s Seniors… Read More
CSRxP: STRONGER Patents Act Could Further Enable Big Pharma’s Patent Abuse
Proposed Bill Would Undermine Fair and Efficient Review Process Washington,… Read More
In Case You Missed It: Congress must capitalize on momentum to hold Big Pharma accountable
Lauren Aronson The Hill July 9, 2019 The American people are demanding that… Read More
CSRxP: Judiciary Committee Cracks Down on Big Pharma’s Anti-Competitive Tactics
Senators Advance Three Measures to Help Lower Drug Prices as Momentum to Hold… Read More
CSRxP Applauds Senate HELP Committee For Advancing Bipartisan Measures to Hold Big Pharma Accountable and Lower Drug Prices
Advancement of CREATES and FAIR Drug Pricing Acts Marks Step Toward Boosting… Read More